Recombinant Peptides Ce1 and Ce4 from the Venom of Scorpion Centruroides elegans and Their Interactions with Hybrid Channels KcsA-Kv1.x (x = 1, 3, 6)

[1]  D. Dolgikh,et al.  GFP–Margatoxin, a Genetically Encoded Fluorescent Ligand to Probe Affinity of Kv1.3 Channel Blockers , 2022, International journal of molecular sciences.

[2]  Fernando Castro-Herrera,et al.  Pharmacological blockade of KV1.3 channel as a promising treatment in autoimmune diseases , 2022, Journal of translational autoimmunity.

[3]  A. Todd,et al.  Studying Independent Kcna6 Knock-out Mice Reveals Toxicity of Exogenous LacZ to Central Nociceptor Terminals and Differential Effects of Kv1.6 on Acute and Neuropathic Pain Sensation , 2021, The Journal of Neuroscience.

[4]  L. Pardo,et al.  Discovery of KV1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges , 2021, Medicinal research reviews.

[5]  H. Wulff,et al.  Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling , 2020, Channels.

[6]  A. Liantonio,et al.  Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches , 2020, International journal of molecular sciences.

[7]  L. Chow,et al.  The versatile Kv channels in the nervous system: actions beyond action potentials , 2020, Cellular and Molecular Life Sciences.

[8]  A. Feofanov,et al.  Fluorescent Ligands of Kv1 Channels on the Basis of Hongotoxin: Atto488-Hongotoxin , 2019, Microscopy and Microanalysis.

[9]  R. Norton,et al.  Peptide therapeutics from venom: Current status and potential. , 2017, Bioorganic & medicinal chemistry.

[10]  E. Muñoz-Elías,et al.  Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial , 2017, PloS one.

[11]  Yuliya V. Korolkova,et al.  Complexes of Peptide Blockers with Kv1.6 Pore Domain: Molecular Modeling and Studies with KcsA-Kv1.6 Channel , 2017, Journal of Neuroimmune Pharmacology.

[12]  M. Kirpichnikov,et al.  Straightforward approach to produce recombinant scorpion toxins-Pore blockers of potassium channels. , 2017, Journal of biotechnology.

[13]  E. Grishin,et al.  Fluorescent protein-scorpion toxin chimera is a convenient molecular tool for studies of potassium channels , 2016, Scientific Reports.

[14]  E. Grishin,et al.  Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins , 2015, Biochemistry (Moscow).

[15]  Z. Varga,et al.  Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels. , 2014, Toxicon : official journal of the International Society on Toxinology.

[16]  Shin-Ho Chung,et al.  Binding Modes of Two Scorpion Toxins to the Voltage-Gated Potassium Channel Kv1.3 Revealed from Molecular Dynamics , 2014, Toxins.

[17]  E. Campbell,et al.  Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K+ channel , 2013, eLife.

[18]  E. Grishin,et al.  Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study , 2013, Analytical and Bioanalytical Chemistry.

[19]  R. Latorre,et al.  K(+) channels: function-structural overview. , 2012, Comprehensive Physiology.

[20]  Y. Jan,et al.  Voltage‐gated potassium channels and the diversity of electrical signalling , 2012, The Journal of physiology.

[21]  Heike Wulff,et al.  Voltage-gated potassium channels as therapeutic targets , 2009, Nature Reviews Drug Discovery.

[22]  A. Morielli,et al.  Kv1.3 channels in postganglionic sympathetic neurons: expression, function, and modulation. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  P. Calabresi,et al.  Characterization of the Functional Properties of the Voltage-Gated Potassium Channel Kv1.3 in Human CD4+ T Lymphocytes1 , 2007, The Journal of Immunology.

[24]  H. Gruppen,et al.  Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis. , 2007, Journal of agricultural and food chemistry.

[25]  S. Confort-Gouny,et al.  Block of neural Kv1.1 potassium channels for neuroinflammatory disease therapy , 2006, Annals of neurology.

[26]  Juan A. Fernández,et al.  Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells. , 2005, Toxicon : official journal of the International Society on Toxinology.

[27]  R. C. Rodríguez de la Vega,et al.  Novel interactions between K+ channels and scorpion toxins. , 2003, Trends in pharmacological sciences.

[28]  K. Chandy,et al.  Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressants. , 2001, Toxicon : official journal of the International Society on Toxinology.

[29]  O. Pongs,et al.  Generating a High Affinity Scorpion Toxin Receptor in KcsA-Kv1.3 Chimeric Potassium Channels* , 2000, The Journal of Biological Chemistry.

[30]  A. Koschak,et al.  Subunit Composition of Brain Voltage-gated Potassium Channels Determined by Hongotoxin-1, a Novel Peptide Derived fromCentruroides limbatus Venom* , 1998, The Journal of Biological Chemistry.

[31]  R. MacKinnon,et al.  Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. , 1994, Biochemistry.

[32]  G A Gutman,et al.  Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. , 1994, Molecular pharmacology.

[33]  E. Grishin,et al.  Potassium Channel Blockers in Mesobuthus eupeus 1 Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: an Integrated Transcriptomic and Proteomic Study* , 2015 .

[34]  J. Tropea,et al.  Expression and purification of soluble His(6)-tagged TEV protease. , 2009, Methods in molecular biology.

[35]  K. Giangiacomo,et al.  Molecular basis of alpha-KTx specificity. , 2004, Toxicon : official journal of the International Society on Toxinology.